Pharmaceuticals

Pediatric Vaccine Industry Poised for Rapid Growth, Forecast to Touch $107.8 Billion by 2030 at 13.5% CAGR

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pediatric vaccine market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Pediatric Vaccine Market’s size between 2026 and 2030?

The market for pediatric vaccines has experienced substantial expansion in recent times. This market is projected to expand from $57.51 billion in 2025 to $65.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.0%. Historically, this expansion has been driven by factors such as an increasing incidence of preventable childhood illnesses, immunization initiatives spearheaded by governments, innovations in vaccine adjuvants, heightened understanding of pediatric health, and the development of cold chain infrastructure.

The pediatric vaccine market is projected to experience swift expansion over the coming years. This market is set to reach $107.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. The anticipated growth during this period stems from factors such as advancements in mRNA and DNA vaccine technologies, a rise in investment dedicated to pediatric vaccine research and development (R&D), the incorporation of digital health monitoring systems, the development of healthcare infrastructure in nascent markets, and collaborations forged between biotechnology companies and international health bodies. Key trends for the forecast duration encompass an enhanced emphasis on ensuring vaccine accessibility in economically disadvantaged areas, a greater uptake of combination vaccines, the broadening of school-based immunization initiatives, the creation of innovative pediatric vaccines for uncommon diseases, and an increase in public-private collaborations within vaccine research.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Which Drivers Are Shaping Strategic Decisions In The Pediatric Vaccine Market?

The expanding incidence of chronic ailments such as tuberculosis, diphtheria, and pneumonia among individuals aged 15 and below is anticipated to propel the growth of the pediatric vaccines market. There is an increasing danger of severe disease outcomes and complications from infectious diseases for children and adolescents afflicted with chronic conditions. For example, in June 2024, information from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels, insufficient to be categorized as diabetes) in 2023, which signifies an 18% surge from 3,065,825 cases recorded in 2022. Therefore, the escalating prevalence of chronic diseases is acting as a primary driver for the pediatric vaccine market’s expansion.

What Segment Classifications Make Up The Pediatric Vaccine Market?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

How Are New Market Trends Shaping The Landscape Of The Pediatric Vaccine Market?

Leading firms within the pediatric vaccine market are prioritizing obtaining product approvals to more effectively address the requirements of their current clientele. ABRYSVO is a vaccine authorized by the FDA for use in pregnant women, designed to avert lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in children till 6 months of age. For instance, in August 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, disclosed the U.S. FDA approval of Pfizer’s ABRYSVO vaccine for the Avoidance of Respiratory Syncytial Virus (RSV) in Infants through the active immunization of pregnant women 32-36 weeks gestational age. This marks the inaugural and sole maternal vaccination approved in the United States intended to shield newborns from lower respiratory tract illness (LRTD) and severe LRTD caused by RSV, from birth to six months of age.

Which Key Players Are Driving Competition In The Pediatric Vaccine Market?

Major companies operating in the pediatric vaccine market are Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Daiichi Sankyo, CSL Limited, Sinopharm, Walvax Biotechnology, Fosun Pharma, MCM Vaccine Company, Seqirus, Johnson & Johnson, Connaught Laboratories Inc., Wyeth-Ayerst, Ataulfo de Paiva Foundation, Bio-Manguinhos – Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Region Is Projected To Lead The Pediatric Vaccine Market During The Forecast Period?

North America was the largest region in the pediatric vaccine market in 2025. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pediatric Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2824&type=smp

Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2026, By The Business Research Company

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Adult Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795